Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis
Summary Background Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject...
Gespeichert in:
Veröffentlicht in: | Alimentary pharmacology & therapeutics 2024-05, Vol.59 (9), p.1049-1061 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1061 |
---|---|
container_issue | 9 |
container_start_page | 1049 |
container_title | Alimentary pharmacology & therapeutics |
container_volume | 59 |
creator | Ramirez‐Cadiz, Carolina Blaney, Hanna Kubanek, Natalia Díaz, Luis Antonio Loomba, Rohit Skladany, Lubomir Arab, Juan Pablo |
description | Summary
Background
Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate.
Aims
To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH.
Methods
We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’
Results
Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use.
Conclusions
While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed. |
doi_str_mv | 10.1111/apt.17948 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2956687255</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3034668289</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3488-7b77244f8b5ee1e6277ac5df4be80f0ac22a3f036b9e1dc9c8e7dd0cddd108d13</originalsourceid><addsrcrecordid>eNp1kc9KHTEUh4O06O21C19AAt3YxWj-zEwy3cmltoKgiF2HTHIGI7mTaZJR7k7oC_iMfZJGr3ZRaDaHkO98nJwfQgeUHNNyTvSUj6noarmDFpS3TcUIb9-hBWFtVzFJ-R76kNIdIaQVhO2iPS5r0ciOL9Cva7h38IB1zM54-IJXc4wwZuxG64zOLowJ69HiBB7M8xWb6DJEp_EQIgYd_QZ7dw8R56jHNHk95pe-oihd5QGw9ibcBv_78UmnFIzTGSy-halw2aV99H7QPsHH17pEP86-3qy-VxeX385XpxeV4bWUleiFYHU9yL4BoNAyIbRp7FD3IMlAtGFM86H8vO-AWtMZCcJaYqy1lEhL-RIdbb1TDD9nSFmtXTLgy8QQ5qRY17StFKxpCvrpH_QuzHEs0ylOeF0wVta3RJ-3lIkhpQiDmqJb67hRlKjnZFRJRr0kU9jDV-Pcr8H-Jd-iKMDJFnhwHjb_N6nTq5ut8g98kJxq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3034668289</pqid></control><display><type>article</type><title>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Wiley Online Library All Journals</source><creator>Ramirez‐Cadiz, Carolina ; Blaney, Hanna ; Kubanek, Natalia ; Díaz, Luis Antonio ; Loomba, Rohit ; Skladany, Lubomir ; Arab, Juan Pablo</creator><creatorcontrib>Ramirez‐Cadiz, Carolina ; Blaney, Hanna ; Kubanek, Natalia ; Díaz, Luis Antonio ; Loomba, Rohit ; Skladany, Lubomir ; Arab, Juan Pablo</creatorcontrib><description>Summary
Background
Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate.
Aims
To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH.
Methods
We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’
Results
Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use.
Conclusions
While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.</description><identifier>ISSN: 0269-2813</identifier><identifier>ISSN: 1365-2036</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.17948</identifier><identifier>PMID: 38475893</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Abstinence ; alcohol ; Alcohol use ; alcohol use disorders ; alcoholic hepatitis ; alcoholic liver disease ; Alcoholism - complications ; alcohol‐associated hepatitis ; cirrhosis ; Hepatitis ; Hepatitis, Alcoholic - complications ; Hepatitis, Alcoholic - diagnosis ; Hepatitis, Alcoholic - surgery ; Humans ; Inflammation ; Liver diseases ; Liver Diseases, Alcoholic - complications ; Liver transplantation ; Liver Transplantation - adverse effects ; Liver transplants ; Patient Selection ; Survival</subject><ispartof>Alimentary pharmacology & therapeutics, 2024-05, Vol.59 (9), p.1049-1061</ispartof><rights>2024 The Authors. published by John Wiley & Sons Ltd.</rights><rights>2024 The Authors. Alimentary Pharmacology & Therapeutics published by John Wiley & Sons Ltd.</rights><rights>2024. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3488-7b77244f8b5ee1e6277ac5df4be80f0ac22a3f036b9e1dc9c8e7dd0cddd108d13</cites><orcidid>0000-0002-4845-9991 ; 0000-0003-4919-9519 ; 0000-0002-8561-396X ; 0000-0001-9905-7741 ; 0000-0002-6805-0560 ; 0000-0002-8540-4930 ; 0000-0001-5171-3623</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.17948$$EPDF$$P50$$Gwiley$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.17948$$EHTML$$P50$$Gwiley$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38475893$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramirez‐Cadiz, Carolina</creatorcontrib><creatorcontrib>Blaney, Hanna</creatorcontrib><creatorcontrib>Kubanek, Natalia</creatorcontrib><creatorcontrib>Díaz, Luis Antonio</creatorcontrib><creatorcontrib>Loomba, Rohit</creatorcontrib><creatorcontrib>Skladany, Lubomir</creatorcontrib><creatorcontrib>Arab, Juan Pablo</creatorcontrib><title>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</title><title>Alimentary pharmacology & therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>Summary
Background
Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate.
Aims
To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH.
Methods
We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’
Results
Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use.
Conclusions
While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.</description><subject>Abstinence</subject><subject>alcohol</subject><subject>Alcohol use</subject><subject>alcohol use disorders</subject><subject>alcoholic hepatitis</subject><subject>alcoholic liver disease</subject><subject>Alcoholism - complications</subject><subject>alcohol‐associated hepatitis</subject><subject>cirrhosis</subject><subject>Hepatitis</subject><subject>Hepatitis, Alcoholic - complications</subject><subject>Hepatitis, Alcoholic - diagnosis</subject><subject>Hepatitis, Alcoholic - surgery</subject><subject>Humans</subject><subject>Inflammation</subject><subject>Liver diseases</subject><subject>Liver Diseases, Alcoholic - complications</subject><subject>Liver transplantation</subject><subject>Liver Transplantation - adverse effects</subject><subject>Liver transplants</subject><subject>Patient Selection</subject><subject>Survival</subject><issn>0269-2813</issn><issn>1365-2036</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><recordid>eNp1kc9KHTEUh4O06O21C19AAt3YxWj-zEwy3cmltoKgiF2HTHIGI7mTaZJR7k7oC_iMfZJGr3ZRaDaHkO98nJwfQgeUHNNyTvSUj6noarmDFpS3TcUIb9-hBWFtVzFJ-R76kNIdIaQVhO2iPS5r0ciOL9Cva7h38IB1zM54-IJXc4wwZuxG64zOLowJ69HiBB7M8xWb6DJEp_EQIgYd_QZ7dw8R56jHNHk95pe-oihd5QGw9ibcBv_78UmnFIzTGSy-halw2aV99H7QPsHH17pEP86-3qy-VxeX385XpxeV4bWUleiFYHU9yL4BoNAyIbRp7FD3IMlAtGFM86H8vO-AWtMZCcJaYqy1lEhL-RIdbb1TDD9nSFmtXTLgy8QQ5qRY17StFKxpCvrpH_QuzHEs0ylOeF0wVta3RJ-3lIkhpQiDmqJb67hRlKjnZFRJRr0kU9jDV-Pcr8H-Jd-iKMDJFnhwHjb_N6nTq5ut8g98kJxq</recordid><startdate>202405</startdate><enddate>202405</enddate><creator>Ramirez‐Cadiz, Carolina</creator><creator>Blaney, Hanna</creator><creator>Kubanek, Natalia</creator><creator>Díaz, Luis Antonio</creator><creator>Loomba, Rohit</creator><creator>Skladany, Lubomir</creator><creator>Arab, Juan Pablo</creator><general>Wiley Subscription Services, Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4845-9991</orcidid><orcidid>https://orcid.org/0000-0003-4919-9519</orcidid><orcidid>https://orcid.org/0000-0002-8561-396X</orcidid><orcidid>https://orcid.org/0000-0001-9905-7741</orcidid><orcidid>https://orcid.org/0000-0002-6805-0560</orcidid><orcidid>https://orcid.org/0000-0002-8540-4930</orcidid><orcidid>https://orcid.org/0000-0001-5171-3623</orcidid></search><sort><creationdate>202405</creationdate><title>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</title><author>Ramirez‐Cadiz, Carolina ; Blaney, Hanna ; Kubanek, Natalia ; Díaz, Luis Antonio ; Loomba, Rohit ; Skladany, Lubomir ; Arab, Juan Pablo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3488-7b77244f8b5ee1e6277ac5df4be80f0ac22a3f036b9e1dc9c8e7dd0cddd108d13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abstinence</topic><topic>alcohol</topic><topic>Alcohol use</topic><topic>alcohol use disorders</topic><topic>alcoholic hepatitis</topic><topic>alcoholic liver disease</topic><topic>Alcoholism - complications</topic><topic>alcohol‐associated hepatitis</topic><topic>cirrhosis</topic><topic>Hepatitis</topic><topic>Hepatitis, Alcoholic - complications</topic><topic>Hepatitis, Alcoholic - diagnosis</topic><topic>Hepatitis, Alcoholic - surgery</topic><topic>Humans</topic><topic>Inflammation</topic><topic>Liver diseases</topic><topic>Liver Diseases, Alcoholic - complications</topic><topic>Liver transplantation</topic><topic>Liver Transplantation - adverse effects</topic><topic>Liver transplants</topic><topic>Patient Selection</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramirez‐Cadiz, Carolina</creatorcontrib><creatorcontrib>Blaney, Hanna</creatorcontrib><creatorcontrib>Kubanek, Natalia</creatorcontrib><creatorcontrib>Díaz, Luis Antonio</creatorcontrib><creatorcontrib>Loomba, Rohit</creatorcontrib><creatorcontrib>Skladany, Lubomir</creatorcontrib><creatorcontrib>Arab, Juan Pablo</creatorcontrib><collection>Wiley Online Library Open Access</collection><collection>Wiley Free Content</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramirez‐Cadiz, Carolina</au><au>Blaney, Hanna</au><au>Kubanek, Natalia</au><au>Díaz, Luis Antonio</au><au>Loomba, Rohit</au><au>Skladany, Lubomir</au><au>Arab, Juan Pablo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2024-05</date><risdate>2024</risdate><volume>59</volume><issue>9</issue><spage>1049</spage><epage>1061</epage><pages>1049-1061</pages><issn>0269-2813</issn><issn>1365-2036</issn><eissn>1365-2036</eissn><abstract>Summary
Background
Alcohol‐associated hepatitis (AH) is a severe inflammatory form of alcohol‐associated liver disease (ALD) that carries a high mortality rate. Early liver transplantation for severe AH is increasingly available. However, specific criteria for referral and selection remain a subject of debate.
Aims
To provide a narrative review of the natural history, diagnostic criteria and indications for referral for early liver transplantation for severe AH.
Methods
We searched PubMed for articles published through August 2023. Key search terms were ‘alcoholic hepatitis,’ ‘alcohol‐associated hepatitis,’ ‘abstinence,’ ‘alcohol relapse,’ and ‘liver transplantation.’
Results
Previously, a six‐month period of alcohol abstinence was required before patients with ALD were considered for liver transplantation. However, studies in recent years have demonstrated that, among carefully selected patients, patients who received early transplants have much higher survival rates than patients with similarly severe disease who did not undergo transplants (77% vs. 23%). Despite these successes, early liver transplantation remains controversial, as these patients have typically not undergone treatment for alcohol use disorder, with the ensuing risk of returning to alcohol use.
Conclusions
While early liver transplantation for AH has survival benefits, many patients would not have received treatment for alcohol use disorder. An integrated approach to evaluating candidacy for early liver transplantation is needed.</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>38475893</pmid><doi>10.1111/apt.17948</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-4845-9991</orcidid><orcidid>https://orcid.org/0000-0003-4919-9519</orcidid><orcidid>https://orcid.org/0000-0002-8561-396X</orcidid><orcidid>https://orcid.org/0000-0001-9905-7741</orcidid><orcidid>https://orcid.org/0000-0002-6805-0560</orcidid><orcidid>https://orcid.org/0000-0002-8540-4930</orcidid><orcidid>https://orcid.org/0000-0001-5171-3623</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0269-2813 |
ispartof | Alimentary pharmacology & therapeutics, 2024-05, Vol.59 (9), p.1049-1061 |
issn | 0269-2813 1365-2036 1365-2036 |
language | eng |
recordid | cdi_proquest_miscellaneous_2956687255 |
source | MEDLINE; EZB-FREE-00999 freely available EZB journals; Wiley Online Library All Journals |
subjects | Abstinence alcohol Alcohol use alcohol use disorders alcoholic hepatitis alcoholic liver disease Alcoholism - complications alcohol‐associated hepatitis cirrhosis Hepatitis Hepatitis, Alcoholic - complications Hepatitis, Alcoholic - diagnosis Hepatitis, Alcoholic - surgery Humans Inflammation Liver diseases Liver Diseases, Alcoholic - complications Liver transplantation Liver Transplantation - adverse effects Liver transplants Patient Selection Survival |
title | Review article: Current indications and selection criteria for early liver transplantation in severe alcohol‐associated hepatitis |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T21%3A18%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Review%20article:%20Current%20indications%20and%20selection%20criteria%20for%20early%20liver%20transplantation%20in%20severe%20alcohol%E2%80%90associated%20hepatitis&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Ramirez%E2%80%90Cadiz,%20Carolina&rft.date=2024-05&rft.volume=59&rft.issue=9&rft.spage=1049&rft.epage=1061&rft.pages=1049-1061&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.17948&rft_dat=%3Cproquest_cross%3E3034668289%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3034668289&rft_id=info:pmid/38475893&rfr_iscdi=true |